Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Targeted Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Vertex
Eli Lilly
Teva
Incyte
Gilead
Celgene
Pfizer
Novartis
AbbVie
Sanofi
By Type:
Cancer Growth Blocker Drug
Other
Monoclonal Antibody
By Application:
Diagnostic & Reference Laboratories
Hospitals
Academic & Research Institutes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Targeted Cancer Drugs Market Overview 2018-2029
-
1.1 China Targeted Cancer Drugs Industry Development Overview
-
1.2 China Targeted Cancer Drugs Industry Development History
-
1.3 China Targeted Cancer Drugs Industry Market Size (2018-2029)
-
1.4 China Targeted Cancer Drugs Market Analysis by Type from Production Side
-
1.4.1 China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Cancer Growth Blocker Drug (2018-2029)
-
1.4.2 China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.3 China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
1.5 China Targeted Cancer Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic & Reference Laboratories (2018-2029)
-
1.5.2 China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.3 China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Academic & Research Institutes (2018-2029)
-
1.6 China Targeted Cancer Drugs Market Analysis by Region
-
1.6.1 North China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Targeted Cancer Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Targeted Cancer Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Targeted Cancer Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Targeted Cancer Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Targeted Cancer Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Targeted Cancer Drugs Industry Development
Chapter 3 Targeted Cancer DrugsIndustry Chain Analysis
-
3.1 Targeted Cancer Drugs Industry Chain
-
3.2 Targeted Cancer Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Targeted Cancer Drugs Market
-
3.3 Targeted Cancer Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Targeted Cancer Drugs Market
Chapter 4 China Targeted Cancer Drugs Market, by Type
-
4.1 China Targeted Cancer Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Targeted Cancer Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Targeted Cancer Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Targeted Cancer Drugs Production Volume and Growth Rate of Cancer Growth Blocker Drug
-
4.5.2 China Targeted Cancer Drugs Production Volume and Growth Rate of Other
-
4.5.3 China Targeted Cancer Drugs Production Volume and Growth Rate of Monoclonal Antibody
Chapter 5 China Targeted Cancer Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Targeted Cancer Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Targeted Cancer Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Targeted Cancer Drugs Market Size and Growth Rate of Diagnostic & Reference Laboratories
-
5.5.2 China Targeted Cancer Drugs Market Size and Growth Rate of Hospitals
-
5.5.3 China Targeted Cancer Drugs Market Size and Growth Rate of Academic & Research Institutes
Chapter 6 China Targeted Cancer Drugs Market, by Region
-
6.1 China Targeted Cancer Drugs Production Volume and Production Value, by Region
-
6.2 China Targeted Cancer Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Targeted Cancer Drugs Market Analysis
-
7.1 North China Targeted Cancer Drugs Market, by Type
-
7.2 North China Targeted Cancer Drugs Market, by Application
Chapter 8 Central China Targeted Cancer Drugs Market Analysis
-
8.1 Central China Targeted Cancer Drugs Market, by Type
-
8.2 Central China Targeted Cancer Drugs Market, by Application
Chapter 9 South China Targeted Cancer Drugs Market Analysis
-
9.1 South China Targeted Cancer Drugs Market, by Type
-
9.2 South China Targeted Cancer Drugs Market, by Application
Chapter 10 East China Targeted Cancer Drugs Market Analysis
-
10.1 East China Targeted Cancer Drugs Market, by Type
-
10.2 East China Targeted Cancer Drugs Market, by Application
Chapter 11 Northeast China Targeted Cancer Drugs Market Analysis
-
11.1 Northeast China Targeted Cancer Drugs Market, by Type
-
11.2 Northeast China Targeted Cancer Drugs Market, by Application
Chapter 12 Southwest China Targeted Cancer Drugs Market Analysis
-
12.1 Southwest China Targeted Cancer Drugs Market, by Type
-
12.2 Southwest China Targeted Cancer Drugs Market, by Application
Chapter 13 Northwest China Targeted Cancer Drugs Market Analysis
-
13.1 Northwest China Targeted Cancer Drugs Market, by Type
-
13.2 Northwest China Targeted Cancer Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Vertex
-
14.1.1 Vertex Company Profile
-
14.1.2 Vertex Targeted Cancer Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Profile
-
14.2.2 Eli Lilly Targeted Cancer Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Teva
-
14.3.1 Teva Company Profile
-
14.3.2 Teva Targeted Cancer Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Incyte
-
14.4.1 Incyte Company Profile
-
14.4.2 Incyte Targeted Cancer Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Gilead
-
14.5.1 Gilead Company Profile
-
14.5.2 Gilead Targeted Cancer Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Celgene
-
14.6.1 Celgene Company Profile
-
14.6.2 Celgene Targeted Cancer Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer
-
14.7.1 Pfizer Company Profile
-
14.7.2 Pfizer Targeted Cancer Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis
-
14.8.1 Novartis Company Profile
-
14.8.2 Novartis Targeted Cancer Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 AbbVie
-
14.9.1 AbbVie Company Profile
-
14.9.2 AbbVie Targeted Cancer Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Sanofi
-
14.10.1 Sanofi Company Profile
-
14.10.2 Sanofi Targeted Cancer Drugs Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Targeted Cancer Drugs Industry Research Conclusions
-
15.2 Targeted Cancer Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Targeted Cancer Drugs Industry Market Size (2018-2029)
-
Figure China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Cancer Growth Blocker Drug (2018-2029)
-
Figure China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Targeted Cancer Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
Figure China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic & Reference Laboratories (2018-2029)
-
Figure China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate of Academic & Research Institutes (2018-2029)
-
Figure North China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Targeted Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Targeted Cancer Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Targeted Cancer Drugs Market Share by Type in 2018
-
Figure China Targeted Cancer Drugs Market Share by Type in 2023
-
Figure China Targeted Cancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Targeted Cancer Drugs Production Volume and Growth Rate of Cancer Growth Blocker Drug (2018-2023)
-
Figure China Targeted Cancer Drugs Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Targeted Cancer Drugs Production Volume and Growth Rate of Monoclonal Antibody (2018-2023)
-
Figure China Targeted Cancer Drugs Market Share by Application in 2018
-
Figure China Targeted Cancer Drugs Market Share by Application in 2023
-
Figure China Targeted Cancer Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Targeted Cancer Drugs Market Size and Growth Rate of Diagnostic & Reference Laboratories (2018-2023)
-
Figure China Targeted Cancer Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Targeted Cancer Drugs Market Size and Growth Rate of Academic & Research Institutes (2018-2023)
-
Table China Targeted Cancer Drugs Production Volume by Region (2018-2023)
-
Table China Targeted Cancer Drugs Production Volume Share by Region (2018-2023)
-
Figure China Targeted Cancer Drugs Production Volume Share by Region (2018-2023)
-
Table China Targeted Cancer Drugs Production Value by Region (2018-2023)
-
Table China Targeted Cancer Drugs Production Value Share by Region (2018-2023)
-
Figure China Targeted Cancer Drugs Production Value Share by Region (2018-2023)
-
Table China Targeted Cancer Drugs Sales Volume by Region (2018-2023)
-
Table China Targeted Cancer Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Targeted Cancer Drugs Sales Volume Share by Region (2018-2023)
-
Table China Targeted Cancer Drugs Sales Value by Region (2018-2023)
-
Table China Targeted Cancer Drugs Sales Value Share by Region (2018-2023)
-
Figure China Targeted Cancer Drugs Sales Value Share by Region (2018-2023)
-
Table North China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table North China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table North China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table North China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table Central China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Central China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table South China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table South China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table South China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table East China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table East China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table East China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Targeted Cancer Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Targeted Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Targeted Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Targeted Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Vertex Company Profile
-
Table Vertex Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Teva Company Profile
-
Table Teva Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Incyte Company Profile
-
Table Incyte Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Gilead Company Profile
-
Table Gilead Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Targeted Cancer Drugs Revenue, Price and Gross (2018-2023)
-
